Lung transplant drug trial halted: new inhaled therapy shows promise but study ends early
Disease control
Terminated
This study tested an inhaled form of cyclosporine A (L-CsA) plus standard care in 164 people who had a lung transplant and developed bronchiolitis obliterans, a condition that scars the small airways. The goal was to see if the treatment could slow lung function decline over 24 t…
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 11, 2026 20:40 UTC